Invention Grant
- Patent Title: 1,3-thiazol-2-yl substituted benzamides
-
Application No.: US15820429Application Date: 2017-11-21
-
Publication No.: US10202369B2Publication Date: 2019-02-12
- Inventor: Adam James Davenport , Nico Bräuer , Oliver Martin Fischer , Andrea Rotgeri , Antje Rottmann , Ioana Neagoe , Jens Nagel , Anne-Marie Godinho-Coelho , Jürgen Klar
- Applicant: BAYER AKTIENGESELLSCHAFT
- Applicant Address: DE Leverkusen
- Assignee: Bayer Aktiengesellschaft
- Current Assignee: Bayer Aktiengesellschaft
- Current Assignee Address: DE Leverkusen
- Agency: Morrison & Foerster LLP
- Priority: EP14196954 20141209
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61P13/10 ; C07D417/12 ; C07D417/14 ; A61P25/28 ; A61P31/18 ; A61P25/16 ; A61P29/00 ; A61P13/00 ; A61P31/04 ; C07D471/08 ; C07D498/08
Abstract:
The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neurogenic disorder, as a sole agent or in combination with other active ingredients.
Public/Granted literature
- US20180093980A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES Public/Granted day:2018-04-05
Information query
IPC分类:
